home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

FDA's Proposed Rule Regarding Device Establishment Registration and Listing

 
  February 15, 2011  
     
 


ComplianceOnline, Online Event
2011-03-10


Learn about the proposed Device Establishment Registration and Listing rule and how to meet the FDA requirements and expectations.

Why Should You Attend: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. FDA issued a 28-page Proposed Rule that would amend its regulations regarding medical device establishment registration and device listing (the Proposed Rule).

The Proposed Rule contains four types of proposed changes to FDA’s device establishment registration and device listing regulations. The Proposed Rule, if finalized, would require establishments to provide additional or different information than specified in the current regulations, but which FDA now requests via FURLS. This Webinar will provide latest update as well as a “refresh” overview on how to register your device company and list your device(s) correctly and meeting requirements and expectation regardless of the outcome of the Proposed Rule.

Areas Covered in the Seminar:

  • When and how to register and list.
  • Review the four proposed changes to FDA’s device establishment registration and device listing regulations.
  • Proposed changes to Implement the provision of Bioterrorism Act applicable to imported devices.
  • Other proposed Amendments that would change current device establishment registration and listing requirements.
  • Replacement of the current regulations regarding updating device listing information outside the required update periods.
  • Clarification of who must provide establishments’ registration numbers.

Who Will Benefit:

This webinar will provide valuable assistance and guidance to medical device firms, importers and those who need to register their device firms and list their device(s). The employees who will benefit include: All levels of management and departmental representatives and those who desire a better understanding or a "refresh" overview of the establishment registration and listing process from start to finish, including:

  • Regulatory Affairs
  • Quality and Compliance
  • Marketing & Sales
  • Importers
  • Distributors/Authorized Representatives
  • Legal Counsel
  • Engineering/Technical Services/Operations
  • Consultants
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount. 
 
 
Organized by: ComplianceOnline
Invited Speakers:
David R. Dills, an independent Regulatory & Compliance Consultant with more than 22 years of hands-on experience and a proven track record within the life sciences and FDA regulated industry, has an extensive regulatory background with Class I/II/III and IVD devices and managing and handling activities within the global regulatory landscape. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, provides guidance on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses EU regulatory requirements regarding MDD and CE Mark. Background encompasses broad capabilities in quality systems, validation, regulatory affairs, compliance, auditing, interfacing with the regulatory agencies, Notified Bodies, AR’s and demonstrates credible experience to maximize business performance in the devices arena. He strives to optimize business performance through proactive strategies to mitigate compliance exposure by providing strategic and tactical solutions that facilitate the achievement of regulatory milestones.
 
Deadline for Abstracts: 2011-03-10
 
Registration:

Attend Live Online Training

$249.00 One Dial-in One Attendee

$999.00 Group–Max. 10 Attendees

(For multiple locations contact Customer Care)

E-mail: admin@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.